Professor | TANAKA Yasuhito ytanaka(at mark)kumamoto-u.ac.jp |
---|---|
Associate Professor | NAOE Hideaki naoh(at mark)kumamoto-u.ac.jp |
Assistant Professor | WATANABE Takehisa twatanabe(at mark)kumadai.jp |
Our department emphasizes the fusion of basic and clinical research with the motto of original and clinically useful research. We are committed to prevention, diagnosis and treatment, and provide advanced medical care for a wide range of diseases, including liver cancer, esophageal cancer,
pancreatic cancer, viral hepatitis, lifestyle-related liver disease, and inflammatory bowel disease (IBD). We also make full use of the latest endoscopic procedures to ensure early detection and treatment.
In terms of research, we focus on basic research, omics research and translational research, and promote original research such as exosome
(miRNA) research using novel devices and soft palate analysis using AI. It is also working to realize personalized treatment for gastrointestinal cancers through the development of cancer genomic medicine. In addition, as a representative of the AMED (Japan Medical Research and Development Organization) research group, we are currently developing a nationwide multi-center collaborative research program and is also focusing on drug discovery research for hepatitis B, aiming to develop new treatment methods through collaboration with companies and physician-led clinical trials.
The department is striving to bring the results of cutting-edge research back to patients and is constantly working toward provide optimal medical care for each individual patient.